Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-21-035564
Filing Date
2021-07-02
Accepted
2021-07-02 16:15:40
Documents
4

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 2 TO FORM S-1 ea143585-posama2_citius.htm POS AM 291343
2 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP ea143585ex5-1_citius.htm EX-5.1 6207
3 CONSENT OF WOLF & COMPANY, P.C ea143585ex23-1_citius.htm EX-23.1 2287
4 GRAPHIC image_001.jpg GRAPHIC 13550
  Complete submission text file 0001213900-21-035564.txt   319811
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: POS AM | Act: 33 | File No.: 333-217956 | Film No.: 211070240
SIC: 2834 Pharmaceutical Preparations